At a glance
ClinicalIndex Comparison RecordN/ACompleted· 156 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Retrospective Observational Study Of Patients Previously Treated With Tigecycline In ICU And Included In The Previous French Prospective Observational Study
In Brief
An observational study for Survival Status at Day 30 After the Last Intake. Completed, enrolled 156 participants across 21 sites.
Detailed Summary
The goal of this retrospective observational study is to collect only status survival data 30 days after the last dose of treatment of patients included in the initial protocol WYETH 3074A1-4448 / B1811030. The purpose is to estimate the survival status, 30 days after the last intake of tigecycline to patients hospitalized in ICU and treated by tigecycline.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesFrance
Collaborators--
Timeline
N/ACompletedFinished
20132014201520162017201820192020202120222023202420252026
Enrollment StartFeb 2013
First PostedApr 2013
Primary CompletionJul 2013
TodayJul 2026
First PostedApr 25, 2013
Enrollment StartFeb 1, 2013
Primary CompletionJul 1, 2013
TodayJul 2, 2026
Enrollment to primary: 5 monthsPosted 13.2 years ago